Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Waning humoral immunity following monkeypox virus infection and vaccination, Canada, 2020 to 2023.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Same author

Searching for immune correlates in Lassa vaccine development - workshop report.

NPJ vaccines·2026
Same author

Pathogenicity and antiviral treatment of clade Ib Monkeypox virus infection in mice.

Antiviral research·2026
Same author

Assessment of three antiviral compounds against Borealpox virus infection in a mouse model.

Emerging microbes & infections·2026
Same author

Inhibitory effects of molnupiravir on Crimean-Congo hemorrhagic fever virus polymerase.

NAR molecular medicine·2026
Same author

Age- and sex-associated differences in Lujo hemorrhagic fever pathogenesis in strain 13/N guinea pigs.

PLoS neglected tropical diseases·2025
Same journal

Combination adjuvants: clinical value and mechanisms of action.

Current opinion in virology·2026
Same journal

Editorial Overview: Immunopathogenesis in viral disease.

Current opinion in virology·2026
Same journal

Architecture and evolution of viral complement evasion.

Current opinion in virology·2026
Same journal

The HEV capsid through a dynamic lens: parallels and divergence from caliciviruses.

Current opinion in virology·2026
Same journal

When structural rationales fall short: revisiting the immunogenicity of herpesvirus prefusion and postfusion glycoprotein B.

Current opinion in virology·2026
Same journal

Beyond brain fog: viral proteins as convergent drivers of neuroinflammation and proteinopathy.

Current opinion in virology·2026
See all related articles

Related Experiment Video

Updated: May 14, 2026

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
09:07

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses

Published on: January 20, 2017

Animal models for highly pathogenic emerging viruses.

David Safronetz1, Thomas W Geisbert, Heinz Feldmann

  • 1Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rocky Mountain Laboratories, Hamilton, MT, USA.

Current Opinion in Virology
|February 14, 2013
PubMed
Summary
This summary is machine-generated.

Emerging viral diseases pose significant threats. Animal models are crucial for understanding pathogenesis and developing medical countermeasures against these highly pathogenic viruses.

More Related Videos

Influenza A Virus Studies in a Mouse Model of Infection
10:44

Influenza A Virus Studies in a Mouse Model of Infection

Published on: September 7, 2017

Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses
08:10

Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses

Published on: January 15, 2020

Related Experiment Videos

Last Updated: May 14, 2026

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
09:07

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses

Published on: January 20, 2017

Influenza A Virus Studies in a Mouse Model of Infection
10:44

Influenza A Virus Studies in a Mouse Model of Infection

Published on: September 7, 2017

Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses
08:10

Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses

Published on: January 15, 2020

Area of Science:

  • Virology
  • Pathogenesis
  • Epidemiology

Background:

  • Emerging viral pathogens like Lujo virus, Severe Fever with Thrombocytopenia Syndrome virus, and SARS-like coronaviruses cause high morbidity and mortality.
  • The sporadic nature of these infections hinders disease understanding and the development of medical countermeasures.
  • Animal models are essential tools for studying disease pathogenesis and evaluating interventions.

Purpose of the Study:

  • To review the current status of animal disease models for highly pathogenic and emerging viral pathogens.
  • To emphasize the importance of animal models that accurately recapitulate human disease for predictive data.
  • To identify potential targets for intervention and evaluate therapeutics and vaccines.

Main Methods:

  • Literature review of existing animal models for emerging viral pathogens.
  • Analysis of the ability of models to mimic human disease conditions.
  • Evaluation of model utility in understanding pathogenesis and testing countermeasures.

Main Results:

  • The article provides an overview of current animal models for various emerging viral diseases.
  • It highlights the challenges in developing and validating these models.
  • The review underscores the critical role of well-chosen animal models in advancing research.

Conclusions:

  • Accurate animal models are imperative for understanding emerging viral pathogens and developing effective medical countermeasures.
  • Continued development and validation of predictive animal models are necessary for public health preparedness.
  • These models are vital for assessing the efficacy of vaccines and therapeutics against novel viral threats.